Our Board of Trustees, a collective of outstanding personalities, entrepreneurs, and world-renowned pioneers in Radiomolecular Precision Oncology, is united by a deep dedication to the Quantalpha Foundation‘s mission to scale patient access to theranostics globally. Their joint commitment and contributions, spanning across continents, significantly contribute to building a growing global community, advocacy, and expanding infrastructure to help service growing numbers of cancer patients worldwide.